Biological Modulation of Bacterial QSSMs, Innate and Adaptive Immunity by Antibiotics, Probiotics and Prebiotics in Healthy Individuals
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Serum QSSM level
研究概览
简要总结
It has recently been discovered that bacteria are able to communicate using specialised molecules known as Quorum Sensing Signalling Molecules (QSSMs). An accumulation of QSSMs in their surrounding environment allow for the bacteria to quantify the size of colonies. At specific colony sizes the concentration of QSSMs reaches a critical threshold leading to the activation of genes that cause an infection. It is by this mechanism that bacteria within a colony coordinate behaviour to activate infectivity when colony sizes are large enough to withstand defensive measures from the host's immune system. A disruption of quorum sensing may reduce the severity of infection and this has led to the development of inhibitors of quorum sensing as a new strategy in antibacterial therapy.
QSSMs are also thought to facilitate infection by other mechanisms and are able to influence the number and function of a specific type of immune cell known as an 'antigen presenting cell'. These cells are pivotal in allowing the immune system to recognise components of bacteria as foreign and thereby mount the appropriate response. It was found that large numbers of these types of cells underwent programmed cell death (cell suicide) in the presence of QSSMs compared to when QSSMs were absent. This mirrors the situation in blood sampled from patients with severe infections where there is a greater proportion of cell deaths among antigen presenting cells than other types of immune cell.
This study aims to establish in healthy volunteers, the mechanisms by which QSSMs affect immune cells and facilitate the spread of infection. Antibiotic administration in humans can alter the environment of the intestine and can lead to an overgrowth of harmful bacteria to potentially cause an infection. Probiotics supplements can prevent bacterial overgrowth and potentially reduce infective complications. The mechanism, which we aim to clarify, may involve changes in both the production of QSSMs and the function of immune cells.
Hypothesis
- Antibiotic use alters gut flora, leading to the appearance in the systemic circulation of bacterial QSSMs and changes in immune function of the host.
- Probiotics and/or prebiotics have beneficial effects by preserving the normal resident gut flora, thereby, modulating bacterial QSSMs and preserving the immune function of the host.
Aims
The aims of our study are 2 fold:
- Firstly, to study the effect of orally administered antibiotic on QSSMs (in faeces and blood) and on innate and adaptive immunity in healthy humans.
- Secondly, to study the effect of orally administered combinations of prebiotic, probiotic and antibiotic on QSSMs (in faeces and blood) and on innate and adaptive immunity in healthy humans.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Factorial
- 主要目的
- Basic Science
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 75 Years(Adult, Older Adult)
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Male volunteers
- •Age 18-55 years
- •Willing to participate and able to give informed consent
- •Alcohol abstinence during study
排除标准
- •Smokers/substance abusers
- •Individuals with diabetes mellitus
- •Oral/Intravenous steroids
- •Allergy to azithromycin
- •Individuals already taking regular medications/probiotics/nutritional supplements
- •Individuals with chronic disease or currently under investigation
- •Individuals with ≤3 bowel movements/week
- •Individuals with ≥2 bowel movements/day
研究组 & 干预措施
Placebo/Probiotic
干预措施: Bifidobacterium longum BB536 (Dietary Supplement)
Placebo/Probiotic
干预措施: Azithromycin (Drug)
Placebo/Prebiotic
干预措施: Active hexose correlated compound (AHCC) (Dietary Supplement)
Placebo/Prebiotic
干预措施: Azithromycin (Drug)
Prebiotic/Probiotic
干预措施: Bifidobacterium longum BB536 and Active hexose correlated compound (AHCC) (Dietary Supplement)
Prebiotic/Probiotic
干预措施: Azithromycin (Drug)
Placebo/Placebo
干预措施: Corn starch placebo capsule (Dietary Supplement)
Placebo/Placebo
干预措施: Azithromycin (Drug)
结局指标
主要结局
Serum QSSM level
时间窗: 14 days
次要结局
- T cell Th1/Th2 ratio(14 days)
